Company news

Valneva SE news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

VALNEVA Declaration of shares and voting rights: June 30, 2025

July 3, 2025

Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus

June 26, 2025

Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance

June 25, 2025

Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®

June 5, 2025

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

June 4, 2025

Valneva to Participate at U.S. and European Investor Conferences in June

May 26, 2025

Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States

May 12, 2025

Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly

May 7, 2025

Valneva Reports First Quarter 2025 Financial Results and Provides Corporate Updates

May 7, 2025

← Newer news releases

Calls

The 5 newest of 16 calls. Every call is listed under its year.

Decks

The 5 newest of 80 decks. Every deck is listed under its year.